title: Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model.
abstract: Long-standing or repeated skin barrier damage followed by atopic dermatitis (AD) is the initial step of the atopic march that eventually progresses to respiratory allergies. Maintenance of an acidic pH in the stratum corneum (SC) is an important factor for normal skin barrier function. We performed this study to determine whether an oxazolone (Ox)-induced AD murine model can develop airway inflammation by topical application and nasal inhalation of a house dust mite, Dermatofagoides pteronyssinus (Dp), which is a novel 'atopic march animal model', and whether an acidic SC environment, made by repeated application of acidic cream, can interrupt this atopic march. During repeated treatment with Ox and Dp to make an atopic march murine model, acidic cream (pH 2.8) and neutral cream (pH 7.4) adjusted by citric acid and sodium hydroxide mixed with vehicle were applied twice daily. Repeated treatment with Ox and Dp to hairless mice induced AD-like skin lesions followed by respiratory allergy, defining it as an atopic march model. Acidic cream inhibited the occurrence of respiratory allergic inflammation as well as AD-like skin lesions. These results indicate that a novel atopic march animal model can be developed by repeated topical and nasal treatments with house dust mite on Ox-induced AD mice and that the acidification of SC could be a novel intervention method to block the atopic march.
authors: Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea.
authors: Hae-Jin
authors: HJ
authors: Lee
authors: Na Young
authors: NY
authors: Yoon
authors: Noo Ri
authors: NR
authors: Lee
authors: Minyoung
authors: M
authors: Jung
authors: Dong Hye
authors: DH
authors: Kim
authors: Eung Ho
authors: EH
authors: Choi
mesh_terms: D000280:Administration, Inhalation; D000287:Administration, Topical; D000485:Allergens / Q000008:administration & dosage; D000818:Animals; D039741:Antigens, Dermatophagoides / Q000008:administration & dosage / Q000633:toxicity; D001249:Asthma / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D016207:Cytokines / Q000097:blood; D003876:Dermatitis, Atopic / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D004195:Disease Models, Animal; D005260:Female; D006863:Hydrogen-Ion Concentration; D007073:Immunoglobulin E / Q000097:blood; D051379:Mice; D008812:Mice, Hairless; D010081:Oxazolone / Q000008:administration & dosage / Q000633:toxicity; D063465:Skin Cream / Q000008:administration & dosage* / Q000737:chemistry*; D000094632:Thymic Stromal Lymphopoietin
chemical_list: D000485:Allergens; D039741:Antigens, Dermatophagoides; D016207:Cytokines; D010081:Oxazolone; D007073:Immunoglobulin E; D000094632:Thymic Stromal Lymphopoietin; C000721967:TSLP protein, mouse
keywords: Dermatofagoides pteronyssinus; acid; atopic dermatitis; atopic march; oxazolone